Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page
- Check5 days agoChange DetectedResults status changed from 'No Results Posted' to 'Results Submitted'. This indicates that the study results have been submitted for posting and are awaiting publication.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded revision label v3.5.0 and removed revision label v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No study content or user-facing information appears to be affected.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision notices (v3.4.2 and v3.4.1) are minor platform updates and do not alter study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a site-wide notice about government funding lapse and the NIH Clinical Center status with guidance to check updates. Updated the page revision to v3.4.1 and removed the previous v3.4.0 revision.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria and Last Update Posted) along with a new page revision tag (Revision: v3.4.0). Minor capitalization and wording updates (e.g., No FEAR Act Data) were applied, replacing the previous text and version (v3.3.4).SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.